Outcomes among secondary prevention implantable cardioverter-defibrillator recipients aged ≥80 years at time of implant in the West of Scotland: A 7-year retrospective review
Published online on July 14, 2026
Abstract
Scottish Medical Journal, Volume 71, Issue 3, Page 87-91, August 2026.
Introduction and aimsGuidelines recommend secondary prevention implantable cardioverter defibrillator (SP-ICD) therapy after significant ventricular arrhythmia. However, landmark SP-ICD trials enrolled patients with mean ages of 58–65 years. No randomised ...
Introduction and aimsGuidelines recommend secondary prevention implantable cardioverter defibrillator (SP-ICD) therapy after significant ventricular arrhythmia. However, landmark SP-ICD trials enrolled patients with mean ages of 58–65 years. No randomised ...